The hon. Gentleman speaks with authority because he knows the reality. He will also know that pharmaceutical batches must be checked to ensure that the quality and ingredients are right. That work has to be done in a European Union country in order for those products to be sold within the European Union, so this pharmaceutical company it is going to replicate exactly the same brilliant labs that it has in Broxtowe and in Nottingham over in Amsterdam. This is the stuff of madness. The company is looking at flying qualified, high-skilled technicians out to Amsterdam on a weekly, if not daily basis, to do the work there. Replication adds to costs, and I have no doubt that it will not be long before the senior managers simply say, “Why on earth are we doing it in the UK, facing the end of the customs union and the single markets, when we could simply go into another country in the European Union and replicate our manufacturing process there?”
Customs and Borders
Proceeding contribution from
Anna Soubry
(Conservative)
in the House of Commons on Thursday, 26 April 2018.
It occurred during Backbench debate on Customs and Borders.
About this proceeding contribution
Reference
639 c1083 Session
2017-19Chamber / Committee
House of Commons chamberSubjects
Librarians' tools
Timestamp
2019-11-13 16:39:50 +0000
URI
http://hansard.intranet.data.parliament.uk/Commons/2018-04-26/18042639000296
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2018-04-26/18042639000296
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2018-04-26/18042639000296